BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29107298)

  • 1. KLK5 induces shedding of DPP4 from circulatory Th17 cells in type 2 diabetes.
    Nargis T; Kumar K; Ghosh AR; Sharma A; Rudra D; Sen D; Chakrabarti S; Mukhopadhyay S; Ganguly D; Chakrabarti P
    Mol Metab; 2017 Nov; 6(11):1529-1539. PubMed ID: 29107298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD26/DPP4 levels in peripheral blood and T cells in patients with type 2 diabetes mellitus.
    Lee SA; Kim YR; Yang EJ; Kwon EJ; Kim SH; Kang SH; Park DB; Oh BC; Kim J; Heo ST; Koh G; Lee DH
    J Clin Endocrinol Metab; 2013 Jun; 98(6):2553-61. PubMed ID: 23539735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased shedding dipeptidyl peptidase 4 from membrane in Hashimoto's thyroiditis.
    Xu W; Liu Y; Cheng X; Huang N; Hou N; Wang H; Han F; Han X; Sun X
    Int Immunopharmacol; 2020 Apr; 81():106315. PubMed ID: 32086131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Greater circulating DPP4 activity is associated with impaired flow-mediated dilatation in adults with type 2 diabetes mellitus.
    Barchetta I; Ciccarelli G; Barone E; Cimini FA; Ceccarelli V; Bertoccini L; Sentinelli F; Tramutola A; Del Ben M; Angelico F; Baroni MG; Lenzi A; Cavallo MG
    Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1087-1094. PubMed ID: 31431395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of circulatory DPP4 activity in metabolic diseases.
    Nargis T; Chakrabarti P
    IUBMB Life; 2018 Feb; 70(2):112-119. PubMed ID: 29331088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.
    Klemann C; Wagner L; Stephan M; von Hörsten S
    Clin Exp Immunol; 2016 Jul; 185(1):1-21. PubMed ID: 26919392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic DPP4 activity is reduced during primary HIV-1 infection and is associated with intestinal RORC
    Ploquin MJ; Casrouge A; Madec Y; Noël N; Jacquelin B; Huot N; Duffy D; Jochems SP; Micci L; Lécuroux C; Boufassa F; Booiman T; Garcia-Tellez T; Ghislain M; Grand RL; Lambotte O; Kootstra N; Meyer L; Goujard C; Paiardini M; Albert ML; Müller-Trutwin M
    J Int AIDS Soc; 2018 Jul; 21(7):e25144. PubMed ID: 29987877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice.
    Nishina S; Yamauchi A; Kawaguchi T; Kaku K; Goto M; Sasaki K; Hara Y; Tomiyama Y; Kuribayashi F; Torimura T; Hino K
    Cell Mol Gastroenterol Hepatol; 2019; 7(1):115-134. PubMed ID: 30510994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of DPP4 Gene Polymorphisms with Type 2 Diabetes Mellitus in Malaysian Subjects.
    Ahmed RH; Huri HZ; Al-Hamodi Z; Salem SD; Al-Absi B; Muniandy S
    PLoS One; 2016; 11(4):e0154369. PubMed ID: 27111895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic individuals with COVID-19 exhibit reduced efficacy of gliptins in inhibiting dipeptidyl peptidase 4 (DPP4). A suggested explanation for increased COVID-19 susceptibility in patients with type 2 diabetes mellitus (T2DM).
    Mora-Rodríguez JM; Sánchez BG; Bort A; Díaz-Yuste A; Ballester-González R; Arrieta F; Sebastián-Martín A; Díaz-Laviada I
    Life Sci; 2024 Jan; 336():122292. PubMed ID: 38030058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of DPP4 activity and sDPP4 are dissociated from inflammation in mice and humans.
    Baggio LL; Varin EM; Koehler JA; Cao X; Lokhnygina Y; Stevens SR; Holman RR; Drucker DJ
    Nat Commun; 2020 Jul; 11(1):3766. PubMed ID: 32724076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating dipeptidyl peptidase-4 activity correlates with measures of hepatocyte apoptosis and fibrosis in non-alcoholic fatty liver disease in type 2 diabetes mellitus and obesity: A dual cohort cross-sectional study.
    Williams KH; Vieira De Ribeiro AJ; Prakoso E; Veillard AS; Shackel NA; Brooks B; Bu Y; Cavanagh E; Raleigh J; McLennan SV; McCaughan GW; Keane FM; Zekry A; Gorrell MD; Twigg SM
    J Diabetes; 2015 Nov; 7(6):809-19. PubMed ID: 25350950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinctive CD26 Expression on CD4 T-Cell Subsets.
    Cordero OJ; Rafael-Vidal C; Varela-Calviño R; Calviño-Sampedro C; Malvar-Fernández B; García S; Viñuela JE; Pego-Reigosa JM
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Th17 cells express high levels of enzymatically active dipeptidylpeptidase IV (CD26).
    Bengsch B; Seigel B; Flecken T; Wolanski J; Blum HE; Thimme R
    J Immunol; 2012 Jun; 188(11):5438-47. PubMed ID: 22539793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased plasma dipeptidyl peptidase-4 activities are associated with high prevalence of subclinical atherosclerosis in Chinese patients with newly diagnosed type 2 diabetes: a cross-sectional study.
    Zheng TP; Liu YH; Yang LX; Qin SH; Liu HB
    Atherosclerosis; 2015 Oct; 242(2):580-8. PubMed ID: 26318108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization and validation of a fluorogenic dipeptidyl peptidase 4 enzymatic assay in human plasma.
    Yoon H; Cho SH; Seo YR; Yu KS; Park SS; Song MJ
    Anal Biochem; 2021 Jan; 612():113952. PubMed ID: 32926865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DPP4 in cardiometabolic disease: recent insights from the laboratory and clinical trials of DPP4 inhibition.
    Zhong J; Maiseyeu A; Davis SN; Rajagopalan S
    Circ Res; 2015 Apr; 116(8):1491-504. PubMed ID: 25858071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liraglutide alters DPP4 in the circumvallate papillae of type 2 diabetic rats.
    Cao X; Zhou X; Liu XM; Zhou LH
    J Mol Endocrinol; 2016 Jul; 57(1):13-21. PubMed ID: 27151572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipeptidyl peptidase inhibitor therapy in type 2 diabetes: Control of the incretin axis and regulation of postprandial glucose and lipid metabolism.
    Mulvihill EE
    Peptides; 2018 Feb; 100():158-164. PubMed ID: 29412815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of CD26, a potential SARS-CoV-2 receptor, as a biomarker of age and pathology.
    Raha AA; Chakraborty S; Henderson J; Mukaetova-Ladinska E; Zaman S; Trowsdale J; Raha-Chowdhury R
    Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33205807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.